Anqi Dong

414 total citations · 1 hit paper
8 papers, 245 citations indexed

About

Anqi Dong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biotechnology. According to data from OpenAlex, Anqi Dong has authored 8 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Biotechnology. Recurrent topics in Anqi Dong's work include Cancer Research and Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Nanoplatforms for cancer theranostics (2 papers). Anqi Dong is often cited by papers focused on Cancer Research and Treatments (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Nanoplatforms for cancer theranostics (2 papers). Anqi Dong collaborates with scholars based in China. Anqi Dong's co-authors include Jiaoyang Yang, Gege Shu, Dongbao Li, Chao Dong, Jin Zhou, Wenhao Shen, Weikang Li, Yuhong Wang, Lin Hu and Tao Chen and has published in prestigious journals such as Advanced Materials, Oncogene and ACS Applied Materials & Interfaces.

In The Last Decade

Anqi Dong

7 papers receiving 245 citations

Hit Papers

CST1 inhibits ferroptosis and promotes gastric cancer met... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anqi Dong China 5 173 154 127 32 18 8 245
Gege Shu China 4 201 1.2× 154 1.0× 154 1.2× 36 1.1× 17 0.9× 6 262
Jingwan Zhou China 6 225 1.3× 111 0.7× 181 1.4× 31 1.0× 26 1.4× 7 307
Jinchun Xing China 10 220 1.3× 116 0.8× 145 1.1× 39 1.2× 21 1.2× 14 305
Keerthana Gnanapradeepan United States 5 209 1.2× 136 0.9× 168 1.3× 107 3.3× 15 0.8× 6 297
Jinjing Xia China 8 250 1.4× 171 1.1× 172 1.4× 77 2.4× 11 0.6× 14 354
Shicheng Wang China 4 195 1.1× 118 0.8× 105 0.8× 44 1.4× 43 2.4× 10 270
Mathilde Gotanègre France 4 149 0.9× 89 0.6× 73 0.6× 52 1.6× 25 1.4× 4 218
Saifei He China 10 205 1.2× 55 0.4× 149 1.2× 33 1.0× 19 1.1× 17 278
Manqi Meng China 8 159 0.9× 47 0.3× 80 0.6× 37 1.2× 20 1.1× 8 200
Chun-Lin Lin United States 8 205 1.2× 68 0.4× 127 1.0× 78 2.4× 21 1.2× 9 287

Countries citing papers authored by Anqi Dong

Since Specialization
Citations

This map shows the geographic impact of Anqi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Dong more than expected).

Fields of papers citing papers by Anqi Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anqi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Dong. The network helps show where Anqi Dong may publish in the future.

Co-authorship network of co-authors of Anqi Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Anqi Dong. A scholar is included among the top collaborators of Anqi Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anqi Dong. Anqi Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dong, Anqi, Wenhao Shen, Shu Liu, et al.. (2025). NK Cell‐Derived Small Extracellular Vesicles Armed With CLDN4‐Targeting Peptides Potentiate Radiotherapy in Gastric Cancer. Journal of Extracellular Vesicles. 14(11). e70200–e70200.
2.
Peng, Wenlong, Yifan Wang, Anqi Dong, et al.. (2025). Radiation-responsive Salmonella mediate therapeutics precise delivery for synergistic tumor radio-immunotherapy. Journal of Controlled Release. 388(Pt 1). 114292–114292. 1 indexed citations
3.
Wang, Yifan, et al.. (2025). TREM2 scFv‐Engineering Escherichia coli Displaying Modulation of Macrophages to Boost Cancer Radio‐Immunotherapy. Advanced Materials. 37(19). e2417920–e2417920. 11 indexed citations
4.
Hu, Meng‐Yuan, Tingting Li, Mengmeng Xu, et al.. (2025). Engineering Escherichia coli Nissle 1917 Carrying PD1 Agonists Resolves Intestinal Inflammation via Local Immune Modulation. ACS Applied Materials & Interfaces. 17(24). 35099–35115. 1 indexed citations
5.
Yang, Jiaoyang, Gege Shu, Tao Chen, et al.. (2023). ESM1 Interacts with c-Met to Promote Gastric Cancer Peritoneal Metastasis by Inducing Angiogenesis. Cancers. 16(1). 194–194. 22 indexed citations
6.
Li, Dongbao, Yunliang Wang, Anqi Dong, et al.. (2023). Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1α-FBLN5 signaling pathway. British Journal of Cancer. 129(8). 1261–1273. 13 indexed citations
7.
Li, Dongbao, Yuhong Wang, Chao Dong, et al.. (2022). CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. Oncogene. 42(2). 83–98. 192 indexed citations breakdown →
8.
Duan, Kaipeng, Dongbao Li, Jie Pei, et al.. (2022). Risk Factors and Timing of Additional Surgery after Noncurative ESD for Early Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology. 2022. 1–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026